Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ACH · Entity 6858 | Director | May 14, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 80,603 |
Reported balance
After 2026-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 31,191 · Balance 80,603 F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 18, 2026 13:11 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | GrantPhantom Stock · Derivative | 31,191 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-26-000025 · form4.xml · derivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,603 Underlying: Common Stock · 31,191 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 15, 2025 Filed May 16, 2025 22:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 28,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009722 · form4.xml · derivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,412 Underlying: Common Stock · 28,914 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:05 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 11,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009882 · form4.xml · derivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,498 Underlying: Common Stock · 11,154 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 12, 2023 Filed May 12, 2023 23:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 9,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010978 · form4.xml · derivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,344 Underlying: Common Stock · 9,344 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 12, 2022 Filed May 13, 2022 13:09 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 7,600 | $35.32 | $268,432.00 |
DisclosureSEC source: 0001062993-22-012313 · form4.xml · nonDerivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,184 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2022. Read SEC document |
| April 29, 2022 Filed May 3, 2022 12:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011323 · form4.xml · nonDerivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,784 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 20:43 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,098 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000082 · edgar.xml · nonDerivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,853 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 17,242 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000060 · edgar.xml · nonDerivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,755 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| March 05, 2020 Filed Mar 5, 2020 22:21 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 3,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000030 · edgar.xml · nonDerivative · entry 1 Bingham Gwendolyn M · CIK 0001804960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,513 F1 · security: Restricted stock with one year vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.